Drug Uses

Cleocin T is used to treat acne vulgaris.

How Taken

Apply a thin film of Cleocin T Topical Solution or use a Cleocin T Topical Solution pledget for the application of Cleocin T twice daily to affected area. You may use more than one pledget. Use each pledget only once and then discard it.

Warnings/Precautions

It is not known whether clindamycin is excreted in human milk following use of Cleocin T. However, orally and parenterally administered clindamycin has been reported to appear in breast milk.

Missed Dose

If you miss a dose, use it as soon as you remember. If it is near the time of the next dose, skip the missed dose and resume your usual dosing schedule. Do not double the dose to catch up.

Possible Side Effects

Orally and parenterally administered Cleocin T has been associated with severe colitis which may end fatally. Abdominal pain and gastrointestinal disturbances as well as gram-negative folliculitis have also been reported in association with the use of topical formulations of clindamycin.

Storage

Do not use pledget if the seal is broken. Discard after single use. Keep all liquid dosage forms in containers tightly closed out of the reach of children.

Overdose

Topically applied Cleocin T can be absorbed in sufficient amounts to produce systemic effects. Seek emergency medical attention if an overdose is suspected.

More Information

Use caution when taking Cleocin T together with neuromuscular blocking agents.

Disclaimer

This drug information is for your information purposes only, it is not intended that this information covers all uses, directions, drug interactions, precautions, or adverse effects of your medication. This is only general information, and should not be relied on for any purpose. It should not be construed as containing specific instructions for any particular patient. We disclaim all responsibility for the accuracy and reliability of this information, and/or any consequences arising from the use of this information, including damage or adverse consequences to persons or property, however such damages or consequences arise. No warranty, either expressed or implied, is made in regards to this information.

Other info about Cleocin-t-gel at Wikipedia.org and other resources:

UNFPA Welcomes Microbicide Study Results - 20 July 2010
UNITED NATIONS, Vienna/New York—UNFPA joins UNAIDS and its fellow co-sponsoring organizations in welcoming the results of a South African study showing that a vaginal gel containing an antiretroviral drug can significantly reduce the risk of HIV infections in women. These are the first encouraging results since such research into microbicides began nearly 20 years ago. The proof of concept study was completed by the Centre for the AIDS Programme of Research in South Africa.   (Source: UNFPA News)

Apolipoprotein A1 Gene Polymorphism (G-75A and C+83T) in Patients With Myocardial Infarction: A Pilot Study in a North Indian Population.
Authors: Dawar R, Gurtoo A, Singh R The apolipoprotein A1 gene polymorphism (G-75A and C+83T) was studied in 100 subjects (50 patients diagnosed with myocardial infarction and 50 healthy subjects). Serum apolipoprotein (apo) A1 and apo B levels were estimated immunoturbidometrically. Extracted DNA from blood was amplified by polymerase chain reaction, digested with MspI restriction enzyme, run on 8% polyacrylamide gel, and restriction fragment length polymorphism was studied by using a gel documentation system. Serum (mean +/- SD) apo A1 levels were significantly higher in control subjects than the study group (100.80 +/- 7.06 mg/dL [1.0 +/- 0.07 g/L] and 72.56 +/- 9.86 mg/dL [0.73 +/- 0.1 g/L], respectively; P < .0001), whereas apo B levels were significantly lower (72.12 +/- 11.32...

Prevalence and characterization of plasmids carrying sulfonamide resistance genes among Escherichia coli from pigs, pig carcasses and human
Conclusions Sul genes were distributed widely in E. coli isolated from pigs and humans with sul2 being most prevalent. Sul-carrying plasmids belonged to diverse replicon types, but most of detected plasmids were conjugative enabling horizontal transfer. IncFII seems to be the dominant replicon type in sul2-carrying plasmids from all three sources. (Source: BioMed Central)

Use of hemostatic gel in postpartum hemorrhage due to placenta previa.
CONCLUSION:: Hemostatic gel is easily applicable and provides quick and effective hemostatic control in the lower segment, where surgical intervention may be difficult. PMID: 20664443 [PubMed - in process] (Source: Obstetrics and Gynecology)

UNFPA Welcomes Microbicide Study Results - 20 July 2010
UNITED NATIONS, Vienna/New York—UNFPA joins UNAIDS and its fellow co-sponsoring organizations in welcoming the results of a South African study showing that a vaginal gel containing an antiretroviral drug can significantly reduce the risk of HIV infections in women. These are the first encouraging results since such research into microbicides began nearly 20 years ago. The proof of concept study was completed by the Centre for the AIDS Programme of Research in South Africa.   (Source: UNFPA News)